Skip to main content
Clinical Trials/JPRN-jRCTs032190217
JPRN-jRCTs032190217
Completed
Phase 3

Tele-monitoring cardiac rehabilitation using remotely biological signal monitoring system for patients with cardiovascular disease-A pilot study focusing on safety of tele-monitoring cardiac rehabilitation

Yokoyama Miho0 sites12 target enrollmentFebruary 19, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cardiovascular disease
Sponsor
Yokoyama Miho
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Convalescent cardiac rehabilitation using remote biological signal monitoring via the Internet was found to be feasible, with no monitoring problems and improved exercise tolerance. However, it was also shown that IT literacy on the subject side may be important for the realization of implementation.

Registry
who.int
Start Date
February 19, 2020
End Date
July 8, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yokoyama Miho

Eligibility Criteria

Inclusion Criteria

  • 1\. Men and women over 20 years old
  • 2\. Patients who are 140\-185cm tall
  • 3\. One who gained document consent by free will of the research subject after having sufficient explanation for participation in this research, with sufficient understanding.
  • 4\. Patients with cardiovascular disease (coronary artery disease, open heart surgery, chronic heart failure, aortic disease, peripheral artery disease) participating cardiac rehabilitation at Juntendo hospital
  • 5\. Patients who have been stably performing outpatient cardiac rehabilitation for 1 month

Exclusion Criteria

  • 1\. Patients who are weighing over 130kg
  • 2\. Patients with uncontrolled complications
  • 3\. Patients who meet the contraindications, discontinuation criteria for cardiac rehabilitation
  • 4\. Patients with unstable heart disease management
  • 5\. Patients who have cardiovascular events during the first month after outpatient cardiac rehabilitation
  • 6\. Patients who have difficulty in aerobic exercise with bicycle ergometer due to cerebral infarction or orthopedic diseases
  • 7\. Patients who are continuing treatment for malignant neoplas
  • 8\. Any other person who is deemed inappropriate by the Research Director
  • 9\. Pregnant or lactating woman
  • 10\. Men and women who have a pregnancy plan within 22 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials